Skip to main content
. 2021 Jun 11;21:289. doi: 10.1186/s12872-021-02105-3

Table 1.

Characteristics of study participants by atrioventricular block status

Overall Without AV block Participants with AV block
All First degree Second degree Third degree
N 15,181,402 15,092,560 88,842 86,153 2249 440
Age, years
 18–39 7,609,253 (50.1) 7,588,277 (50.3) 20,976 (23.6) 20,072 (23.3) 784 (34.9) 120 (27.3)
 40–59 5,896,375 (38.8) 5,859,173 (38.8) 37,202 (41.9) 36,302 (42.1) 750 (33.3) 150 (34.1)
 ≥ 60 1,675,774 (11.0) 1,645,110 (10.9) 30,664 (34.5) 29,779 (34.6) 715 (31.8) 170 (38.6)
Sex
 Men 8,079,772 (53.2) 8,013,421 (53.1) 66,351 (74.7) 64,499 (74.9) 1567 (69.7) 285 (64.8)
 Women 7,101,630 (46.8) 7,079,139 (46.9) 22,491 (25.3) 21,654 (25.1) 682 (30.3) 155 (35.2)
City size*
 Small city 4,570,409 (30.1) 4,536,248 (30.1) 34,161 (38.5) 33,106 (38.4) 873 (38.8) 182 (41.4)
 Middle city 6,094,497 (40.1) 6,058,120 (40.1) 36,377 (40.9) 35,452 (41.2) 773 (34.4) 152 (34.5)
 Big city 4,516,496 (29.8) 4,498,192 (29.8) 18,304 (20.6) 17,595 (20.4) 603 (26.8) 106 (24.1)
Heart rate, bpm
 < 60 377,629 (3.4) 372,179 (3.4) 5450 (8.3) 4931 (7.7) 360 (21.7) 159 (50.2)
 60–100 10,614,677 (95.6) 10,554,664 (95.6) 60,013 (91.2) 58,570 (91.8) 1285 (77.6) 158 (49.8)
 > 100 115,780 (1.0) 115,443 (1.0) 337 (0.5) 326 (0.5) 11 (0.7) 0
BMI, kg/m2
 < 18.5 640,013 (4.7) 638,248 (4.7) 1765 (2.2) 1646 (2.1) 92 (4.6) 27 (6.8)
 18.5–23.9 6,504,666 (47.6) 6,476,822 (47.7) 27,844 (34.6) 26,731 (34.2) 945 (46.9) 168 (42.3)
 24–27.9 4,690,273 (34.3) 4,655,934 (34.3) 34,339 (42.6) 33,456 (42.8) 730 (36.2) 153 (38.5)
 ≥ 28.0 1,825,423 (13.4) 1,808,789 (13.3) 16,634 (20.6) 16,337 (20.9) 248 (12.3) 49 (12.3)
Hypertension
 No 11,469,363 (78.1) 11,417,566 (78.2) 51,797 (60.3) 50,128 (60.2) 1442 (66.3) 227 (53.5)
 Yes 3,209,2182 (21.9) 3,175,183 (21.8) 34,099 (39.7) 33,168 (39.8) 734 (33.7) 197 (46.5)
Diabetes
 No 13,851,682 (94.9) 13,775,997 (95.0) 75,685 (87.9) 73,307 (87.8) 1990 (91.5) 388 (90.2)
 Yes 749,368 (5.1) 738,904 (5.1) 10,464 (12.1) 10,237 (12.3) 185 (8.5) 42 (9.8)
Low HDL-C
 No 9,477,347 (91.1) 9,415,791 (91.1) 61,556 (87.7) 59,759 (87.6) 1504 (90) 293 (92.7)
 Yes 925,535 (8.9) 916,866 (8.9) 8669 (12.3) 8479 (12.4) 167 (10) 23 (7.3)
High LDL-C
 No 9,700,780 (93.7) 9,635,735 (93.7) 65,045 (92.9) 63,187 (92.9) 1567 (93.9) 291 (92.4)
 Yes 651,784 (6.3) 646,837 (6.3) 4947 (7.1) 4822 (7.1) 101 (6.1) 24 (7.6)
High TC
 No 12,305,558 (91.2) 12,229,928 (91.2) 75,630 (90.3) 73,356 (90.2) 1901 (92.2) 373 (91.4)
 Yes 1,186,254 (8.8) 1,178,085 (8.8) 8169 (9.7) 7974 (9.8) 160 (7.8) 35 (8.6)
High TG
 No 11,386,284 (84.5) 11,318,687 (84.6) 67,597 (80.8) 65,443 (80.6) 1799 (87.6) 355 (87.4)
 Yes 2,082,218 (15.5) 2,066,129 (15.4) 16,089 (19.2) 15,784 (19.4) 254 (12.4) 51 (12.6)

Characteristics of the participants are presented as No. (%) for categorical variables. P < 0.001 for all comparisons between participants with and without AV block

AV atrioventricular, BMI body mass index, Low HDL-C high-density lipoprotein cholesterol < 1.0 mmol/L, High LDL-C low-density lipoprotein cholesterol ≥ 4.1 mmol/L, High TC total cholesterol ≥ 6.2 mmol/L, High TG triglyceride ≥ 2.3 mmol/L

*City size was determined according to urban population size